TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,618,677 | -26.5% | 358,332 | +12.7% | 0.00% | -20.0% |
| Q2 2023 | $26,691,700 | +258.8% | 317,834 | +223.6% | 0.01% | +150.0% |
| Q1 2023 | $7,438,125 | -1.4% | 98,219 | -19.6% | 0.00% | 0.0% |
| Q4 2022 | $7,540,702 | +4.5% | 122,176 | -29.3% | 0.00% | 0.0% |
| Q3 2022 | $7,218,000 | +496.5% | 172,908 | +349.5% | 0.00% | – |
| Q2 2022 | $1,210,000 | +71.6% | 38,466 | +46.9% | 0.00% | – |
| Q1 2022 | $705,000 | +138.2% | 26,179 | +69.6% | 0.00% | – |
| Q4 2021 | $296,000 | -56.9% | 15,439 | -25.5% | 0.00% | – |
| Q3 2021 | $686,000 | -18.5% | 20,717 | -18.3% | 0.00% | – |
| Q2 2021 | $842,000 | -41.8% | 25,367 | -27.3% | 0.00% | – |
| Q1 2021 | $1,447,000 | +502.9% | 34,869 | +188.7% | 0.00% | – |
| Q4 2020 | $240,000 | +36.4% | 12,077 | -5.6% | 0.00% | – |
| Q3 2020 | $176,000 | -41.7% | 12,799 | -24.2% | 0.00% | – |
| Q2 2020 | $302,000 | +69.7% | 16,879 | +14.6% | 0.00% | – |
| Q1 2020 | $178,000 | – | 14,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Must Asset Management Inc. | 94,202 | $5,168,863 | 12.65% |
| Eagle Health Investments LP | 414,205 | $22,677,724 | 5.00% |
| Ophir Asset Management Pty Ltd | 295,761 | $16,192,915 | 3.82% |
| Sandhill Capital Partners LLC | 732,610 | $40,110,409 | 3.75% |
| First Light Asset Management, LLC | 618,100 | $33,840,975 | 3.21% |
| NEXT CENTURY GROWTH INVESTORS LLC | 477,482 | $26,142,139 | 2.84% |
| Bullseye Asset Management LLC | 70,512 | $3,861 | 2.15% |
| Kent Lake Capital LLC | 100,000 | $5,475,000 | 2.10% |
| Nicholas Investment Partners, LP | 413,714 | $22,650,842 | 1.69% |
| AtonRa Partners | 12,287 | $672,713 | 1.41% |